104
Views
6
CrossRef citations to date
0
Altmetric
Acne

Efficacy and safety of artemether emulsion for the treatment of mild-to-moderate acne vulgaris: a randomized pilot study

, , , , , & show all
Pages 762-765 | Received 25 Oct 2019, Accepted 23 Dec 2019, Published online: 08 Jan 2020

References

  • Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Investig Dermatol. 2014;134:1527–1534.
  • Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, et al. Acne vulgaris. Nat Rev Dis Primers . 2015; 1:15029.
  • Dréno B. What is new in the pathophysiology of acne: an overview. J Eur Acad Dermatol Venereol. 2017; 31:8–12.
  • Luk NM, Hui M, Lee HC, et al. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong. J Eur Acad Dermatol Venereol. 2013; 27:31–36.
  • Zeng X, Jiang M, Fu C, et al. Drug resistance analysis of Propionibacterium isolated from skin lesions of acne patients in Wuhan. Chinese J Dermatovenereol. 2014;28(2):131–134.
  • Mei H, Shen Y, Lv G, et al. Sensitivity of Propionibacterium acne to minocycline. Chinese J Leprosy Dermatol. 2015;31:201–203.
  • Sun F, Ling Y, Li M, et al. Resistance of Propionibacterium acne to macrolides and tetracyclines in patients with acne. Chinese J Dermatovenereol. 2017;31:956–957.
  • Li Y. Qinghaosu (artemisinin): chemistry and pharmacology. Acta Pharmacol Sin. 2012;33:1141–1146.
  • Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17:1217–1220.
  • Ho WE, Peh HY, Chan TK, et al. Artemisinins: pharmacological actions beyond anti-malarial. Pharmacol Ther. 2014;142:126–139.
  • Wang GJ, Gao XY, Wu Y, et al. Evaluation of the efficacy and tolerance of artemether emulsion for the treatment of papulopustular rosacea: a randomized pilot study. J Dermatolog Treat. 2019;30:809–812.
  • Li X, Zhu Y, Wang Y, et al. Inhibitory effect of Artemisia annua oil nano-liposome on pathogenic bacteria of acne. J Guangzhou Univ Tradit Chinese Med. 2004;21:122–124.
  • Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379:361–372.
  • Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guide-lines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945–973.
  • Shaheen B, Gonzalez M. A microbial aetiology of acne: what is the evidence? Br J Dermatol. 2011;165:474–485.
  • Gao S, Lu Y, Chen T, et al. In vitro antimicrobial activity of fusidic acid against Staphylococcus epidermidis and Propionibacterium acne in patients with acne vulgaris. Chinese J Dermatol. 2016; 49:658–659.
  • Miao Y. Clinical efficacy and safety of 2% fusidic acid cream in the treatment of bacterial infectious dermatosis. Chin J Mod Drug Appl. 2019;13:12.
  • Chen J, Miao J, Liu M, et al. Different fates of avermectin and artemisinin in China. Sci China Life Sci. 2016;59:634–636.
  • Seif el-Din SH, Al-Hroob AM, Ebeid FA. Schistosoma mansoni: N-acetylcysteine downregulates oxidative stress and enhances the antischistosomal activity of artemether in mice. Exp Parasitol. 2011;128:230–235.
  • Guo Q, Mi X, Zeng F, et al. Effect of artesunate on peripheral blood lymphocyte function in patients with chronic eczema. Practical Med China. 2008;3:17–18.
  • Cuzzocrea S, Saadat F, Di Paola R, et al. Artemether: a new therapeutic strategy in experimental rheumatoid arthritis. Immunopharmacol Immunotoxicol. 2005;27:615–630.
  • Xiao SH, You JQ, Mei JY, et al. Effect of artemether on glucose uptake and glycogen content in Schistosoma japonicum. Zhongguo Yao Li Xue Bao. 1997;18:363–367.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.